InDex Pharmaceuticals Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 105.52 million compared to SEK 56.3 million a year ago. Basic loss per share from continuing operations was SEK 0.2 compared to SEK 0.11 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.404 SEK | 0.00% | +4.39% | +57.81% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+57.81% | 19.86M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- INDEX Stock
- News InDex Pharmaceuticals Holding AB
- InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023